✦ LIBER ✦

Value of COX-2 and HER-2 in judging condition and prognosis in non-small cell lung cancer patients

✍ Scribed by Lei Yang; Jun-guo Lu; Qing-he Tan; Jin-zhi Wei; Xiao-dong Zhang; Hong-bing Gu

Book ID: 107513308
Publisher: Springer-Verlag
Year: 2010
Weight: 494 KB
Volume: 7
Category: Article
ISSN: 1674-5361
DOI: 10.1007/s11805-010-0518-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive value of EGFR and HER2 overex

Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer

✍ Hirsch, F R; Varella-Garcia, M; Cappuzzo, F 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 201 KB

Serum EGF-receptor and HER-2 extracellul

Serum EGF-receptor and HER-2 extracellular domains and prognosis of non-small-cell lung cancer

✍ Jacot, W; Pujol, J-L; Boher, J-M; Lamy, P-J 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 93 KB

Bcl-2 protein and prognosis in patients

Bcl-2 protein and prognosis in patients with potentially curable non-small-cell lung cancer

✍ R. Silvestrini; Aurora Costa; Cosimo Lequaglie; Claudia Mochen; Silvia Veneroni; 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 93 KB

Cyclooxygenase-2 (COX-2) mRNA Expression

Cyclooxygenase-2 (COX-2) mRNA Expression Levels in Normal Lung Tissues and Non-small Cell Lung Cancers

✍ Ochiai, Mari ;Oguri, Tetsuya ;Isobe, Takeshi ;Ishioka, Shinichi ;Yamakido, Michi 📂 Article 📅 1999 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 88 KB

Association of polymorphisms at HORMAD2

Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients

✍ Zhang, Kai; Tang, Shaowen; Cao, Songyu; Hu, Lingmin; Pan, Yun; Ma, Hongxia; Guo, 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 318 KB

Herceptest: Her2 expression and gene amp

Herceptest: Her2 expression and gene amplification in non-small cell lung cancer

✍ G. Cox; M. Vyberg; B. Melgaard; J. Askaa; A. Oster; K.J. O'Byrne 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 343 KB 👁 2 views

HER2 is an erbB/HER type 1 tyrosine kinase receptor that is frequently over-expressed in malignant epithelial tumours. Herceptin, a humanised mouse monoclonal antibody to HER2, is proven therapeutically in the management of metastatic breast cancer, significantly prolonging survival when combined wi